PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
20877132-6	2010	For other cyclooxygenase-2 inhibitors celecoxib, etoricoxib, rofecoxib and valdecoxib, slight to moderate inhibition of hOAT3 only was observed.	Etoricoxib	49-59	solute carrier family 22 member 8	Homo sapiens	120-125	
21457143-0	2011	Inhibitory effect of selective cyclooxygenase-2 inhibitor etoricoxib on human organic anion transporter 3 (hOAT3).	Etoricoxib	58-68	solute carrier family 22 member 8	Homo sapiens	78-105	
21457143-0	2011	Inhibitory effect of selective cyclooxygenase-2 inhibitor etoricoxib on human organic anion transporter 3 (hOAT3).	Etoricoxib	58-68	solute carrier family 22 member 8	Homo sapiens	107-112	
21457143-3	2011	In this study, we evaluated the inhibitory effects of selective cyclooxygenase-2 inhibitor etoricoxib on hOAT3 by uptake experiments using Xenopus laevis oocytes.	Etoricoxib	91-101	solute carrier family 22 member 8	Homo sapiens	105-110	
21457143-4	2011	The injection of hOAT3 cRNA stimulated the uptake of methotrexate into the oocytes, and its transport was inhibited by etoricoxib.	Etoricoxib	119-129	solute carrier family 22 member 8	Homo sapiens	17-22	
21457143-5	2011	Etoricoxib inhibited estrone sulfate uptake by hOAT3 dose dependently, and the 50% inhibitory concentration was estimated to be 9.8 microM.	Etoricoxib	0-10	solute carrier family 22 member 8	Homo sapiens	47-52	
21457143-6	2011	Eadie-Hofstee plot analysis showed that etoricoxib inhibited hOAT3 in a competitive manner.	Etoricoxib	40-50	solute carrier family 22 member 8	Homo sapiens	61-66	
21457143-7	2011	These findings show that etoricoxib has inhibitory effect on hOAT3, and that the potential is comparable to that of traditional NSAIDs.	Etoricoxib	25-35	solute carrier family 22 member 8	Homo sapiens	61-66